Published in J Clin Rheumatol on April 01, 1999
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis (2013) 1.39
Understanding the dose-response relationship of allopurinol: predicting the optimal dosage. Br J Clin Pharmacol (2013) 0.95
Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol (2015) 0.94
Comparative efficacy and safety of urate-lowering therapy for the treatment of hyperuricemia: a systematic review and network meta-analysis. Sci Rep (2016) 0.78
Gout: An old disease in new perspective - A review. J Adv Res (2017) 0.78
[Diagnosis and management of gout in Austria. Survey of current practice considering the EULAR recommendations]. Z Rheumatol (2014) 0.76
Gout: optimizing treatment to achieve a disease cure. Ther Adv Chronic Dis (2016) 0.75
Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects. Drug Des Devel Ther (2015) 0.75
An old disease with new insights: Update on diagnosis and treatment of gout. Eur J Rheumatol (2014) 0.75
Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial. J Adv Res (2017) 0.75
Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum (2002) 1.90
Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout. Ann Rheum Dis (1998) 1.53
Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients. Medicine (Baltimore) (1993) 1.08
Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma. Semin Arthritis Rheum (1986) 1.07
High prevalence of undetected carpal tunnel syndrome in patients with fibromyalgia syndrome. J Rheumatol (1995) 0.98
Sacral insufficiency fractures. High association with pubic rami fractures. Clin Rheumatol (2000) 0.92
Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron (2000) 0.85
Gouty arthritis in the manubriosternal joint. Ann Rheum Dis (1997) 0.78
Efficacy of radiosynovectomy of the knee in rheumatoid arthritis: evaluation with magnetic resonance imaging. Clin Rheumatol (1998) 0.78
POEMS syndrome with neuroarthropathy and nodular regenerative hyperplasia of the liver. Arthritis Rheum (1984) 0.76
Intraarticular urokinase: a new drainage technique for synovial effusions with rice bodies. J Rheumatol (1998) 0.76
[Multicenter comparative study of synthetic salmon calcitonin administered nasally in the treatment of established postmenopausal osteoporosis]. An Med Interna (1995) 0.76
Morphology of spermatozoa in infertile men with and without varicocele. J Androl (1983) 0.75
Fibromyalgia and carpal tunnel syndrome. Ann Rheum Dis (1997) 0.75
Treatment of gout after transplantation. Br J Rheumatol (1998) 0.75
Controlling hyperuricemia. J Rheumatol (1998) 0.75
[Ultrasonography and rheumatology]. Rev Med Brux (2014) 0.75
[Fibromyalgia syndrome (fibrositis): as frequent as it is unknown]. Med Clin (Barc) (1990) 0.75
Carpal tunnel syndrome in scleroderma-like syndromes. J Rheumatol (1985) 0.75
Comparative study of the efficacy and safety of aceclofenac and tenoxicam in rheumatoid arthritis. Clin Rheumatol (1996) 0.75
[Not Available]. Reumatol Clin (2008) 0.75
Fibromyalgia syndrome as a late complication of toxic-oil syndrome. J Rheumatol (1985) 0.75
[Gout, revisited]. Rev Med Brux (2014) 0.75
Spermatozoal density, motility and morphology in fertile and in infertile couples: a mathematical correlation. Acta Eur Fertil (1984) 0.75
[Multifocal encephalopathy as the principle manifestation of an occult cancer]. Rev Clin Esp (1990) 0.75